Facts

• Segment: Healthcare
• Country: Netherlands
• Founded: 2017
• Website: https://vitestro.com

Profile sections

• Summary
• Market context
• Facts
• Funding
• Investors
• Commercial
• Context / Market Position
• Events
• Operations / Deployments
• Relationships
• Customers and deployments
• Record / Articles
• Sources

Summary

Vitestro develops autonomous blood-drawing systems for clinical environments. Its robot combines ultrasound-guided needle placement, computer vision and robotic handling to automate venipuncture workflows in hospitals and diagnostic laboratories.

Market context

Vitestro is one of the clearest examples of medical robotics moving beyond surgery into routine diagnostic workflow automation. Its position is strengthened by CE-marked commercial progress in Europe, strategic backing from major healthcare investors, and a large 2026 Series B aimed at scaling manufacturing, regulatory progress, and commercial readiness. Vitestro develops autonomous blood-collection robotics for clinical workflows, combining vein imaging, robotic needle positioning, sample handling and hospital integration.

Facts

• Website: https://vitestro.com
• HQ: Utrecht, Netherlands
• Founded: 2017
• Segment: Healthcare
• Known funding rounds: 2

Funding

• 2026-03-10 - Series B - $70M - Vitestro raises $70M Series B to advance autonomous robotic phlebotomy and commercial readiness - source: vitestro.com
• 2024-04-30 - Venture round - $22M - Vitestro secures $22 million (€20 million) for autonomous blood draw device - source: vitestro.com

Investors

• EIC Fund - Participant - Vc - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• Invest-NL - Participant - Unknown - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• NYBC Ventures - Lead - Vc - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• Sonder Capital - Lead - Vc - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• Fred Moll - Participant - Angel / Individual - 1 funding event - first seen 2026-03-10
• InterVest - Participant - Unknown - 1 funding event - first seen 2026-03-10
• Labcorp Venture Fund - Participant - Vc - 1 funding event - first seen 2026-03-10
• Mayo Clinic - Participant - Angel / Individual - 1 funding event - first seen 2026-03-10
• MGFO - Participant - Unknown - 1 funding event - first seen 2026-03-10
• PGGM - Participant - Unknown - 1 funding event - first seen 2026-03-10
• Puma Venture Capital - Participant - Vc - 1 funding event - first seen 2026-03-10
• ROM Utrecht - Participant - Angel / Individual - 1 funding event - first seen 2026-03-10
• Sutter Health - Participant - Angel / Individual - 1 funding event - first seen 2026-03-10
• Existing private investors - Participant - Unknown - 1 funding event - first seen 2024-04-30

Commercial

2 commercial events; 2 commercial orders; latest event 2024-05-21

• 2024-05-21 - Commercial order - Danish hospital pre-orders 3 blood drawing devices in first international deployment for Vitestro - source: vitestro.com
• 2024-04-03 - Commercial order - Vitestro secures order from Result Laboratorium for two blood drawing devices - source: vitestro.com

Autonomous robotic blood collection

Vitestro develops autonomous robotic blood-collection systems for clinical settings, including robotic vein finding, needle insertion and sample handling.

• Target environment: Hospitals, outpatient diagnostics and blood-draw workflows.
• Deployment model: Medical robotics deployment model built around a dedicated robotic phlebotomy platform and clinical workflow integration.
• Customer context: Hospitals and diagnostic providers facing staff constraints, repeat blood draws and demand for standardized venipuncture workflows.
• Workflow context: The robot identifies veins, positions the needle, collects diagnostic tubes and supports clinical sample workflows.
• Commercial maturity: Commercializing medical robotics company with European regulatory progress and scale-up financing.
• Market position: Positioned as routine diagnostic automation rather than surgery or general hospital robotics.
• Adoption constraints: Adoption depends on regulatory approvals, clinical evidence, patient acceptance, hospital integration and reliability of venipuncture across populations.
• Adjacent context: Adjacent systems include robotic phlebotomy, automated sample handling, diagnostic lab automation and clinical robotics.
• Source confidence: high

Events

• 2026-03-10 - Funding - Vitestro raises $70M Series B to advance autonomous robotic phlebotomy and commercial readiness - Vitestro raised an oversubscribed $70M Series B to support the next generation of Aletta and broad…
• 2024-08-28 - Production Milestone - Vitestro achieves CE marking for autonomous blood drawing device - Vitestro announced CE marking for its autonomous blood drawing device under the European Medical Device Regulation.
• 2024-05-21 - Commercial Order - Danish hospital pre-orders 3 blood drawing devices in first international deployment for Vitestro - Odense University Hospital signed a pre-order for three Vitestro blood drawing devices.
• 2024-04-30 - Funding - Vitestro secures $22 million (€20 million) for autonomous blood draw device - Vitestro announced a $22 million (€20 million) funding round for its autonomous blood draw device.
• 2024-04-03 - Commercial Order - Vitestro secures order from Result Laboratorium for two blood drawing devices - Result Laboratorium signed an agreement for two Vitestro autonomous blood drawing devices.

Operations / Deployments

• 2026-03-10 - Funding - Vitestro raises $70M Series B to advance autonomous robotic phlebotomy and commercial readiness - Vitestro raised an oversubscribed $70M Series B to support the next generation of Aletta and broad…

Relationships

• autonomous blood-drawing customer - Odense University Hospital pre-ordered three Vitestro autonomous blood-drawing devices.

Customers and deployments

• Production Milestone - 1 source-backed production milestone - 2024-08-28 - Vitestro achieves CE marking for autonomous blood drawing device - source posture: Company Disclosed
• Customer Bound Device Count - 3 autonomous blood-drawing devices pre-ordered - 2024-05-21 - Odense University Hospital - autonomous blood drawing - Odense University Hospital signed a pre-order for three Vitestro autono…

Record / Articles

• 2026-03-10 - Vitestro is turning autonomous blood draws into a supervised clinical workflow layer - A 70 million dollar Series B, European CE marking, and published clinical-trial performance push Aletta from medical ro…